首页
400-620-6333
FGF-9
| 别名 | FGF-9, glia-activating factor (GAF), heparin-binding growth factor 9 (HBGF-9) |
|---|---|
| Compound Class | Peptide |
| 变动原因 | Monomer and homodimer |
| Species |
Human |
| Related Product | FGF-9 |
Summary
| 基因/前体 |
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 是否批准为药物？ | |||||||||||
| IUPAC Name | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide | ||||||||||
| 别名 | FGF-9, glia-activating factor (GAF), heparin-binding growth factor 9 (HBGF-9) |
数据库链接
| UniProtKB | P31371 |
|---|---|
| Wikipedia | FGF9 |
| RCSB PDB Structure | 1IHK |
| Ensembl Gene | ENSG00000102678 |
生物活性
| 生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
|---|
临床资料
| 作用机制与药效学效应 |
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants |
|---|
结构
| Peptide Sequence | LGEVGNYFGVQDAVPFGNVPVLPVDSPVLLSDHLGQSEAGGLPRGPAVTDLDHLKGILRRRQLYCRTGFHLEIFPNGTIQGTRKDHSRFGILEFISIAVGLVSIRGVDSGLYLGMNEKGELYGSEKLTQECVFREQFEENWYNTYSSNLYKHVDTGRRYYVALNKDGTPREGTRTKRHQKFTHFLPRPVDPDKVPELYKDILSQS |
|---|---|
| Post Translation Modifications | Predicted N-linked glycosylation of asparagine residue at position 76 |
危险品化学品经营许可证（带存储）